In parallel, the landscape of pharmacological therapies for T2DM and (to a lesser extent) obesity has expanded in recent decades with new classes of molecules coming into the market
CrossRef G2E3 Suppresses the TumorKilling Function of CD8+ T Cells in Hepatocellular Carcinoma by Boosting CLCN2 Ubiquitination Fan Zhou, Ting Chen, Xingguo Tan, Jun Yu, Mengzhi Xiao, Jun Guo The FASEB Journal .2026;[Epub] CrossRef Tumor burden score determines survival benefit of anatomic resection in hepatocellular carcinoma: A multicenter propensity-matched study Shujie Pang, Yang Shi, Minjun Jiang, Qingwang Ye, Xin Yan, Zhe Sun, Xingrui Kou, Xiaoxiang Chen, Hui SiMa, Yiming Chen, Yingcheng Yang, Ning Yang European Journal of Surgical Oncology .2026
Enzim ini bertanggung jawab dalam pembentukan melanin
Responsabilidade regulatria em um mercado sob ateno crescente O avano da saudabilidade tambm amplia a responsabilidade da indstria na forma como comunica os benefcios de seus produtos
GLP-1 anti-obesity drugs lead to substantial weight loss in the real world March 25, 2024 We know that the GLP-1 anti-obesity drugs lead to substantial weight loss in clinical trials